SMARCB1 and schwannomatosis: Immunohistochemical analysis of VS samples [12] detected a mosaic pattern of INI1 expression in 93% of familial schwannomatosis patients, 55% of sporadic schwannomatosis cases, 83% of NF2-associated tumors, and 5% of solitary sporadic schwannomas.